Trials / Recruiting
RecruitingNCT06420505
Evaluation of the Vivo Isar Stent System in Routine Clinical Practice
Multicenter Observatory Evaluating the Polymer-Free Sirolimus Eluting Coronary Stent System VIVO ISAR in Routine Clinical Practice (CELEBRITY Observatory)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Translumina GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The rationale for this observatory is to evaluate clinical outcomes and collect data of the Polymer Free Sirolimus Eluting Coronary Stent System in Real World CAD Patients with follow-up at 12 months. All medications and procedures to be used/ performed in this observatory are commonly used/performed for clinical indications as part of standard of care and have well-defined safety profiles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Percutaneous Coronary Intervention | The Vivo ISAR is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease. |
Timeline
- Start date
- 2023-11-29
- Primary completion
- 2026-11-29
- Completion
- 2027-01-01
- First posted
- 2024-05-20
- Last updated
- 2024-06-06
Locations
19 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06420505. Inclusion in this directory is not an endorsement.